
DBV Technologies S.A. DBVT
$ 21.59
-0.12%
Quarterly report 2025-Q2
added 07-29-2025
DBV Technologies S.A. Depreciation & Amortization 2011-2026 | DBVT
Annual Depreciation & Amortization DBV Technologies S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.72 M | 3.57 M | 2.7 M | 4.4 M | 4.4 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.4 M | 2.7 M | 3.56 M |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
ARCA biopharma
ABIO
|
27 K | - | 1052.0 % | $ 415 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
19.3 M | $ 18.33 | -0.92 % | $ 2.7 B | ||
|
Amgen
AMGN
|
5.59 B | $ 343.48 | 0.47 % | $ 184 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
22.2 M | $ 72.81 | 5.02 % | $ 9.74 B | ||
|
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M | ||
|
Aytu BioScience
AYTU
|
5.38 M | $ 2.72 | 4.62 % | $ 17.1 M | ||
|
Adagene
ADAG
|
723 K | $ 2.99 | 8.55 % | $ 168 M | ||
|
Biogen
BIIB
|
673 M | $ 177.96 | -1.07 % | $ 25.9 B | ||
|
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | ||
|
Acorda Therapeutics
ACOR
|
31.7 M | - | -24.86 % | $ 820 K | ||
|
Aptose Biosciences
APTO
|
32 K | - | -45.71 % | $ 1.2 M | ||
|
Acasti Pharma
ACST
|
7 K | - | 4.01 % | $ 150 M | ||
|
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
1.58 M | $ 1.4 | -0.71 % | $ 262 M | ||
|
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | ||
|
Allena Pharmaceuticals
ALNA
|
363 K | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
14 K | $ 4.13 | 2.92 % | $ 8.99 B | ||
|
Aravive
ARAV
|
886 K | - | -13.39 % | $ 1.45 M | ||
|
Athira Pharma
ATHA
|
970 K | - | - | $ 269 M | ||
|
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M | ||
|
Autolus Therapeutics plc
AUTL
|
7.55 M | $ 1.39 | 1.09 % | $ 355 M | ||
|
AgeX Therapeutics
AGE
|
131 K | - | -10.17 % | $ 12.2 K | ||
|
AVROBIO
AVRO
|
617 K | - | 1083.1 % | $ 745 M | ||
|
Cardiff Oncology
CRDF
|
404 K | $ 1.72 | -2.0 % | $ 82 M | ||
|
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
9.45 M | - | -15.15 % | $ 60.3 M | ||
|
Brickell Biotech
BBI
|
41 K | - | -5.38 % | $ 6.06 M | ||
|
Amneal Pharmaceuticals
AMRX
|
62.6 M | $ 14.17 | 3.55 % | $ 4.38 B | ||
|
Compugen Ltd.
CGEN
|
461 K | $ 1.85 | 0.27 % | $ 166 M | ||
|
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | ||
|
Atreca
BCEL
|
5.46 M | - | -11.76 % | $ 5.79 M | ||
|
Acer Therapeutics
ACER
|
66 K | - | 2.71 % | $ 14 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
1.25 M | $ 6.68 | 1.52 % | $ 1.38 B | ||
|
Alpine Immune Sciences
ALPN
|
597 K | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
398 K | - | 4.14 % | $ 49.1 M | ||
|
Beam Therapeutics
BEAM
|
21.9 M | $ 28.17 | 1.99 % | $ 2.32 B | ||
|
BeiGene, Ltd.
BGNE
|
172 M | - | 0.49 % | $ 251 B |